Global Blood Therapeutics
Why Robinhood?
You can watch GBT and buy or sell other stocks, ETFs, and their options commission-free!About GBT
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases.
GBT Key Statistics
Stock Snapshot
With a market cap of 4.62B, Global Blood Therapeutics(GBT) trades at $68.49. The stock has a price-to-earnings ratio of -13.70.
On 2026-02-16, Global Blood Therapeutics(GBT) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Global Blood Therapeutics(GBT) stock has reached 0, versus its average volume of 2.06M.
The stock's 52-week range extends from a low of $21.65 to a high of $73.02.
The stock's 52-week range extends from a low of $21.65 to a high of $73.02.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.